
Sanofi is exploring a $35B–$43B takeover of Insmed and its blockbuster lung drug Brinsupri as the French pharma giant braces for Dupixent’s looming patent expiration.
Table of Contents
about 23 years ago
The Ten Billion Dollar Moleculeabout 23 years ago
The Path to Smart R&D




